Skip to main content
XERS
NASDAQ Life Sciences

Xeris Beats Q3 Estimates With 6-Cent EPS and 44% Revenue Growth

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$13.165
Mkt Cap
$2.401B
52W Low
$5.25
52W High
$13.74
52W Position info
151% above low
Off High info
4.2% below high
Rel. Volume info
3.5× avg
Market data snapshot near publication time

XERS has more than doubled off its 52-week low of $5.25 on elevated volume (3.5× avg).

Summary

Xeris delivered Q3 adjusted EPS of 6 cents against a 2-cent consensus, and revenue of $107.23 million versus the $101.52 million analysts expected. Revenue grew 44.2% year over year, with net income of $11.29 million — a swing from the $31.1 million loss in Q2 that was driven by a non-cash debt extinguishment charge. The beat is meaningful for a company this size trading near its 52-week high, and it follows the 8-K filed this morning detailing the quarter. Note the stock's last close referenced in the data was $10.46, below the current $13.165 quote, so shares have already moved sharply on this print. Watch the full-year revenue guidance range of $395M–$405M for the next checkpoint.

At the time of this announcement, XERS was trading at $13.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $5.25 to $13.74. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

XERS - Latest Insights

XERS
Nov 05, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $12.67
Real-time Price: $17.00 info
Change: +$4.33 (+34%) info
Market Cap: $3.1B info
XERS
Nov 05, 2026, 7:12 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $11.48
Real-time Price: $17.00 info
Change: +$5.52 (+48%) info
Market Cap: $3.1B info
XERS
Nov 05, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $10.75
Real-time Price: $17.00 info
Change: +$6.25 (+58%) info
Market Cap: $3.1B info
XERS
Nov 05, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $10.48
Real-time Price: $17.00 info
Change: +$6.52 (+62%) info
Market Cap: $3.1B info
XERS
Sep 09, 2026, 8:33 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.43
Real-time Price: $17.00 info
Change: +$8.57 (+102%) info
Market Cap: $3.1B info